Sunday, December 03, 2017 10:03:39 AM
To many observers the Fortress saga proves that publicly traded alternatives firms aren’t a good idea. One problem, attorney Kaplan says, is the conflicting demands of running a hedge fund and operating a public company: “When you’re running a hedge fund, you’re trying to maximize value and return for investors in the fund, but if you’re a public shareholder, your interest is fees being as big as possible. Instead of running a fund strictly for the benefit of investors, now you’ve got shareholders to be responsible to.” Fortress doesn’t seem to have done well by either.
As Kaplan puts it, “It’s pretty clear now that public ownership is not the future of hedge funds.” And this time around, the principals can’t take the money and run. They will have to reinvest 50 percent of their sale proceeds in either their own funds or those of SoftBank. With the sale of Fortress to SoftBank, the cycle appears to have come full circle.
https://www.institutionalinvestor.com/article/b1505p66vq06cy/the-fall-of-fortress
Who knows, maybe Softbank will want to buy PIOE!
Recent PX News
- P10 Names Melodie Craft as General Counsel • GlobeNewswire Inc. • 04/29/2024 12:30:36 PM
- Bonaccord Capital Partners Acquires Minority Interest in Lead Edge Capital • GlobeNewswire Inc. • 04/24/2024 08:31:09 PM
- P10 Announces Appointment of Tracey Benford to Board of Directors • GlobeNewswire Inc. • 04/22/2024 12:30:58 PM
- Bonaccord Capital Partners Announces Strategic Minority Investment in Lead Edge Capital • GlobeNewswire Inc. • 04/22/2024 11:00:00 AM
- P10 Schedules First Quarter 2024 Earnings Release for Wednesday, May 8, 2024 • GlobeNewswire Inc. • 04/17/2024 08:15:11 PM
- Enhanced Capital Group Named to 13th Annual ImpactAssets 50 List • GlobeNewswire Inc. • 04/03/2024 09:57:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 02:56:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 02:41:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 02:21:15 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 06:30:20 PM
- P10 Reports Fourth Quarter and Full Year 2023 Earnings Results • GlobeNewswire Inc. • 02/29/2024 09:15:03 PM
- Bonaccord Capital Partners Announces JP Armenio as Managing Director and Head of Client Strategies • GlobeNewswire Inc. • 02/20/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:24:17 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:09:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 05:30:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 05:29:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 10:04:34 PM
- P10 Announces Chief Operating Officer William Souder to Retire • GlobeNewswire Inc. • 02/09/2024 10:02:00 PM
- P10 Schedules Fourth Quarter and Full Year 2023 Earnings Release for Thursday, February 29, 2024 • GlobeNewswire Inc. • 02/07/2024 11:15:00 PM
- RCP Advisors Announces Promotions • GlobeNewswire Inc. • 01/30/2024 04:29:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 07:51:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 11:23:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 11:58:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 12:08:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 10:22:38 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM